Ana Ferreira-Vasconcelos
Coimbra, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
Journal: European journal of neurology
Published: February 22, 2022
The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
Journal: Neuropathology and applied neurobiology
Published: April 05, 2021
ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 19, 2020
Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Journal: Advances in experimental medicine and biology
Published: February 11, 2018
Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 13, 2017
Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease.
Journal: Brain : a journal of neurology
Published: May 21, 2015
Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
Journal: Brain : a journal of neurology
Published: June 27, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026